clinical trial glp 1 Lilly orforglipron oral GLP-1 phase 3 weight loss Advancing Clinical Research in GLP-1

J Pharmacol Exp Ther 2003

Kenneth W Mahaffey, Department of Medicine, Stanford Center for Clinical Research, Stanford School of Medicine, Palo Alto, CA, USA

Semaglutide is one of these peptides

in 12 HFpEF patients who underwent bariatric surgery, an improvement in Minnesota Living With Heart Failure score (p=0.018), a lowering in LV myocardial mass (p=0.001) and a reduction in NYHA functional class of HF were observed at 3 and 6 months after surgery

There were minor downsides (some foam after shaking, a little residue in a shaker bottle, and a zip-close bag thats slightly messier than a tub), but the combination of taste and price makes it a good option if youre looking for an organic, plant-based powder